Allogene Therapeutics, Inc. (ALLO) vs Fate Therapeutics, Inc. (FATE)
Detailed comparison between Allogene Therapeutics, Inc., Fate Therapeutics, Inc..Total Return (%)
Allogene Therapeutics, Inc. (ALLO)Fate Therapeutics, Inc. (FATE)
Which stock do you think will perform better?
Allogene Therapeutics, Inc.
ALLO
Fate Therapeutics, Inc.
FATE
| Metric | Allogene Therapeutics, Inc. (ALLO) | Fate Therapeutics, Inc. (FATE) |
|---|---|---|
| Current Price | $1.31 | $1.16 |
| Change | 0.07 (5.69%) | 0.01 (0.86%) |
| Market Cap | $0.29B | $0.13B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.94 | -0.69 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $3.78 | $5.92 |
| 52-Week Low | $0.86 | $0.66 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.22 | $-1.49 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| ALLO | 6.54% | -28.78% | -53.69% | -96.95% | -94.76% | -94.76% |
| FATE | -2.53% | -12.13% | -72.84% | -96.68% | -83.62% | -83.62% |